Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
QH104
i
Other names:
QH104, B7H3 CAR-γδT, QH-104, QH 104
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Suzhou Dushu Lake Hospital
Drug class:
γδ TCR modulator, B7-H3-targeted CAR-T immunotherapy
Related drugs:
‹
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
ACE2016 (2)
ADI-001 (1)
ACE1831 (0)
ADI-002 (0)
BTN2A1/3A1-Fc-CD19scFv (0)
CD7-UCAR-γδT cells (0)
CLN-619 (0)
CTM-N2D (0)
ECT204 (0)
ET 019003 (0)
ET-190 (0)
ET140203 (0)
ET1402L1-ARTEMIS T cells (0)
ET206 (0)
GDT002 (0)
Gamma delta T-cells (0)
ICT01 (0)
INB-100 (0)
INB-200 (0)
INB-300 (0)
autologous γδ T lymphocytes (0)
ALEXIS-ISO-1 (0)
LAVA-051 (0)
LYT-210 (0)
NK/γδ T cell-enriched cell therapy (0)
PF-08046052 (0)
TAK-012 (0)
UTAA06 (0)
anti-CD19-CAR γδT (0)
AVM0703 (0)
γδT Cell infusion (0)
γδT Cell infusion agent (0)
s (1)
4SCAR-276 (0)
B7-H3 CAR-T (0)
BP102 (0)
CAR.B7-H3 T (0)
CD276 CAR-T (0)
GD2, PSMA and CD276 CAR-T (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
KT095 (0)
MT027 (0)
SC-CAR4BRAIN (0)
s (0)
TAA6-CAR-T (0)
Undisclosed EGFR/B7H3 CAR-T (0)
fhB7H3.CAR-Ts (0)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
ACE2016 (2)
ADI-001 (1)
ACE1831 (0)
ADI-002 (0)
BTN2A1/3A1-Fc-CD19scFv (0)
CD7-UCAR-γδT cells (0)
CLN-619 (0)
CTM-N2D (0)
ECT204 (0)
ET 019003 (0)
ET-190 (0)
ET140203 (0)
ET1402L1-ARTEMIS T cells (0)
ET206 (0)
GDT002 (0)
Gamma delta T-cells (0)
ICT01 (0)
INB-100 (0)
INB-200 (0)
INB-300 (0)
autologous γδ T lymphocytes (0)
ALEXIS-ISO-1 (0)
LAVA-051 (0)
LYT-210 (0)
NK/γδ T cell-enriched cell therapy (0)
PF-08046052 (0)
TAK-012 (0)
UTAA06 (0)
anti-CD19-CAR γδT (0)
AVM0703 (0)
γδT Cell infusion (0)
γδT Cell infusion agent (0)
s (1)
4SCAR-276 (0)
B7-H3 CAR-T (0)
BP102 (0)
CAR.B7-H3 T (0)
CD276 CAR-T (0)
GD2, PSMA and CD276 CAR-T (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
KT095 (0)
MT027 (0)
SC-CAR4BRAIN (0)
s (0)
TAA6-CAR-T (0)
Undisclosed EGFR/B7H3 CAR-T (0)
fhB7H3.CAR-Ts (0)
›
Associations
News
Trials
Filter by
Latest
24d
Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection (clinicaltrials.gov)
P1/2, N=25, Suspended, Dushu Lake Hospital Affiliated to Soochow University | Recruiting --> Suspended
24 days ago
Trial suspension
|
CD276 (CD276 Molecule)
|
CD276 expression
|
QH104
1year
Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection (clinicaltrials.gov)
P1/2, N=25, Recruiting, Dushu Lake Hospital Affiliated to Soochow University
1 year ago
New P1/2 trial
|
IL6 (Interleukin 6) • CD276 (CD276 Molecule) • IL10 (Interleukin 10)
|
CD276 expression
|
QH104
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login